Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Liver Diseases

  Free Subscription


1 Ann Intern Med
7 Anticancer Res
2 Biochem Biophys Res Commun
1 BMC Cancer
1 Br J Surg
1 Cancer Res
1 Dig Dis Sci
5 Gastroenterology
2 Gut
2 Hepatology
1 Int J Cancer
1 J Gastroenterol
5 J Hepatol
7 Lancet Gastroenterol Hepatol
1 Oncogene
4 PLoS One
2 Radiology
1 Transplant Proc

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Ann Intern Med

  1. CROWLEY MJ, Diamantidis CJ, McDuffie JR, Cameron CB, et al
    Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review.
    Ann Intern Med. 2017 Jan 3. doi: 10.7326/M16-1901.
    PubMed     Text format     Abstract available

    Anticancer Res

  2. OTTAIANO A, Capozzi M, DE Divitiis C, VON Arx C, et al
    Nab-Paclitaxel and Gemcitabine in Advanced Pancreatic Cancer: The One-year Experience of the National Cancer Institute of Naples.
    Anticancer Res. 2017;37:1975-1978.
    PubMed     Text format     Abstract available

  3. KANAJI N, Kita N, Kadowaki N, Bandoh S, et al
    Fibronectin and Hepatocyte Growth Factor Produced by Lung Fibroblasts Augment Migration and Invasion of Malignant Pleural Mesothelioma Cells.
    Anticancer Res. 2017;37:2393-2400.
    PubMed     Text format     Abstract available

  4. LU LC, Chen PJ, Yeh YC, Hsu CH, et al
    Prescription Patterns of Sorafenib and Outcomes of Patients with Advanced Hepatocellular Carcinoma: A National Population Study.
    Anticancer Res. 2017;37:2593-2599.
    PubMed     Text format     Abstract available

  5. HASHIMOTO M, Kobayashi T, Ishiyama K, Ide K, et al
    Predictive Independent Factors for Extrahepatic Metastasis of Hepatocellular Carcinoma Following Curative Hepatectomy.
    Anticancer Res. 2017;37:2625-2631.
    PubMed     Text format     Abstract available

  6. MIYATA T, Yamashita YI, Yamao T, Umezaki N, et al
    Clinical Benefits of Lymph Node Dissection in Intrahepatic Cholangiocarcinoma: A Retrospective Single-institution Study.
    Anticancer Res. 2017;37:2673-2677.
    PubMed     Text format     Abstract available

  7. HARADA N, Yoshizumi T, Maeda T, Kayashima H, et al
    Preoperative Pancreatic Stiffness by Real-time Tissue Elastography to Predict Pancreatic Fistula After Pancreaticoduodenectomy.
    Anticancer Res. 2017;37:1909-1915.
    PubMed     Text format     Abstract available

  8. TAHARA T, Tahara S, Horiguchi N, Kawamura T, et al
    Telomere Length in Leukocyte DNA in Gastric Cancer Patients and its Association with Clinicopathological Features and Prognosis.
    Anticancer Res. 2017;37:1997-2001.
    PubMed     Text format     Abstract available

    Biochem Biophys Res Commun

  9. YE Y, Chen Q, Li J, Jin L, et al
    CXCL16 deficiency attenuates diabetic nephropathy through decreasing hepatic oxidative stress and inflammation.
    Biochem Biophys Res Commun. 2017 May 3. pii: S0006-291X(17)30859.
    PubMed     Text format     Abstract available

  10. SONG D, Huang H, Wang J, Zhao Y, et al
    NF90 regulates PARP1 mRNA stability in hepatocellular carcinoma.
    Biochem Biophys Res Commun. 2017 May 6. pii: S0006-291X(17)30896.
    PubMed     Text format     Abstract available

    BMC Cancer

  11. KAMIMURA K, Suda T, Yokoo T, Kamimura H, et al
    Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial.
    BMC Cancer. 2017;17:322.
    PubMed     Text format     Abstract available

    Br J Surg

  12. KIM H, Ahn SW, Hong SK, Yoon KC, et al
    Survival benefit of liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma.
    Br J Surg. 2017 May 8. doi: 10.1002/bjs.10541.
    PubMed     Text format     Abstract available

    Cancer Res

  13. QIAO G, Qin J, Kunda N, Calata J, et al
    LIGHT elevation enhances immune eradication of colon cancer metastases.
    Cancer Res. 2017 Mar 1. pii: canres.1655.2016.
    PubMed     Text format     Abstract available

    Dig Dis Sci

  14. TAVAKOLI H, Robinson A, Liu B, Bhuket T, et al
    Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 May 4. doi: 10.1007/s10620-017-4595.
    PubMed     Text format     Abstract available


  15. LOFFREDO L, Pastori D, Farcomeni A, Violi F, et al
    Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: a Systematic Review and Meta-Analysis.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35552.
    PubMed     Text format     Abstract available

  16. KHAN MA, Cholankeril G, Howden CW
    Proton Pump Inhibitors and the Possible Development of Hepatic Encephalopathy in Cirrhotic Patients: True Association or Residual Confounding?
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35404.
    PubMed     Text format    

  17. ROCCARO GA, Goldberg DS
    Early Detection of Hepatocellular Carcinoma after Treatment With Direct-Acting Antivirals: Selection Bias or Biologically Plausible?
    Gastroenterology. 2017 May 3. pii: S0016-5085(17)35551.
    PubMed     Text format    

  18. ASSARAF J, Weiss N, Thabut D
    Proton Pump Inhibitor Administration Triggers Encephalopathy in Cirrhotic Patients by Modulating Blood-Brain Barrier Drug Transport.
    Gastroenterology. 2017 May 4. pii: S0016-5085(17)35403.
    PubMed     Text format    

  19. TAN HK, Leow WQ, Chang PE
    Ruxolitinib for the Treatment of Portal Hypertension in a Patient With Primary Myelofibrosis.
    Gastroenterology. 2017 May 4. pii: S0016-5085(16)35073.
    PubMed     Text format    


  20. THOMAS E
    Hepatitis B virus X protein: TRIMming antiviral defences in hepatocytes.
    Gut. 2017 May 5. pii: gutjnl-2017-314013. doi: 10.1136/gutjnl-2017-314013.
    PubMed     Text format    

  21. PANKOWICZ FP, Jarrett KE, Lagor WR, Bissig KD, et al
    CRISPR/Cas9: at the cutting edge of hepatology.
    Gut. 2017 May 9. pii: gutjnl-2016-313565. doi: 10.1136/gutjnl-2016-313565.
    PubMed     Text format     Abstract available


  22. SLIJEPCEVIC D, Roscam Abbing RLP, Katafuchi T, Blank A, et al
    Hepatic uptake of conjugated bile acids is mediated by both NTCP and OATPs and modulated by intestinal sensing of plasma bile acid levels in mice.
    Hepatology. 2017 May 12. doi: 10.1002/hep.29251.
    PubMed     Text format     Abstract available

  23. DESERT R, Rohart F, Canal F, Sicard M, et al
    Human Hepatocellular Carcinomas with a Periportal Phenotype Have the Lowest Potential for Early Recurrence after Curative Resection.
    Hepatology. 2017 May 12. doi: 10.1002/hep.29254.
    PubMed     Text format     Abstract available

    Int J Cancer

  24. ZHANG D, Zhao L, Shen Q, Lv Q, et al
    Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer.
    Int J Cancer. 2017 Feb 18. doi: 10.1002/ijc.30656.
    PubMed     Text format     Abstract available

    J Gastroenterol

  25. MASUDA K, Ono A, Aikata H, Kawaoka T, et al
    Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy.
    J Gastroenterol. 2017 May 4. doi: 10.1007/s00535-017-1348.
    PubMed     Text format     Abstract available

    J Hepatol

  26. RIPOLL C, Yotti R, Banares R, Bermejo J, et al
    Pressure Volume Curves in Cirrhosis: more than meets the eye.
    J Hepatol. 2017 May 8. pii: S0168-8278(17)32006.
    PubMed     Text format    

  27. TAN-GARCIA A, Wai LE, Zheng D, Ceccarello E, et al
    Intrahepatic CD206+ macrophages contribute to inflammation in advanced viral-related liver disease.
    J Hepatol. 2017 May 5. pii: S0168-8278(17)32004.
    PubMed     Text format     Abstract available

  28. VAUTHEY JN, Mizuno T, Overman MJ, Soubrane O, et al
    Can we navigate chemotherapy-induced hepatic injuries from pathology to bedside?
    J Hepatol. 2017 May 2. pii: S0168-8278(17)30252.
    PubMed     Text format    

  29. MUELLER J, Raisi H, Rausch V, Peccerella T, et al
    Sensitive and non-invasive assessment of hepatocellular iron using a novel room-temperature susceptometer.
    J Hepatol. 2017 May 5. pii: S0168-8278(17)32000.
    PubMed     Text format     Abstract available

  30. LEE S, Kim SH, Lee JE, Sinn DH, et al
    Preoperative Gadoxetic acid-enhanced MRI for Predicting Microvascular Invasion in Patients with Single hepatocellular carcinoma.
    J Hepatol. 2017 May 5. pii: S0168-8278(17)32005.
    PubMed     Text format     Abstract available

    Lancet Gastroenterol Hepatol

  31. SHIMAKAWA Y, Lemoine M
    Early age at diagnosis of hepatocellular carcinoma in sub-Saharan Africa.
    Lancet Gastroenterol Hepatol. 2017;2:393.
    PubMed     Text format    

  32. Correction to Lancet Gastroenterol Hepatol 2017; 2: 427-34.
    Lancet Gastroenterol Hepatol. 2017;2:e3.
    PubMed     Text format    

  33. EL DIKA I, Abou-Alfa GK
    The role (if any) of chemotherapy in hepatocellular carcinoma.
    Lancet Gastroenterol Hepatol. 2017;2:387-389.
    PubMed     Text format    

  34. YANG JD, Roberts LR
    Early age at diagnosis of hepatocellular carcinoma in sub-Saharan Africa - Authors' reply.
    Lancet Gastroenterol Hepatol. 2017;2:394.
    PubMed     Text format    

  35. KUDO M, Moriguchi M, Numata K, Hidaka H, et al
    S-1 versus placebo in patients with sorafenib-refractory advanced hepatocellular carcinoma (S-CUBE): a randomised, double-blind, multicentre, phase 3 trial.
    Lancet Gastroenterol Hepatol. 2017;2:407-417.
    PubMed     Text format     Abstract available

  36. PETTA S, Marzioni M, Russo P, Aghemo A, et al
    Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study.
    Lancet Gastroenterol Hepatol. 2017;2:427-434.
    PubMed     Text format     Abstract available

  37. DE VILLE DE GOYET J, Meyers RL, Tiao GM, Morland B, et al
    Beyond the Milan criteria for liver transplantation in children with hepatic tumours.
    Lancet Gastroenterol Hepatol. 2017;2:456-462.
    PubMed     Text format     Abstract available


  38. XIN B, Yamamoto M, Fujii K, Ooshio T, et al
    Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways.
    Oncogene. 2017 May 8. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available

    PLoS One

  39. WANKHADE UD, Zhong Y, Kang P, Alfaro M, et al
    Enhanced offspring predisposition to steatohepatitis with maternal high-fat diet is associated with epigenetic and microbiome alterations.
    PLoS One. 2017;12:e0175675.
    PubMed     Text format     Abstract available

  40. KANG YM, Jung CH, Cho YK, Lee SE, et al
    Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population.
    PLoS One. 2017;12:e0175762.
    PubMed     Text format     Abstract available

  41. YOON K, Jeong WK, Kim Y, Kim MY, et al
    2-dimensional shear wave elastography: Interobserver agreement and factors related to interobserver discrepancy.
    PLoS One. 2017;12:e0175747.
    PubMed     Text format     Abstract available

  42. ROTH JA, Widmer AF, Tschudin-Sutter S, Dangel M, et al
    The Model for End-stage Liver Disease (MELD) as a predictor of short-term mortality in Staphylococcus aureus bloodstream infection: A single-centre observational study.
    PLoS One. 2017;12:e0175669.
    PubMed     Text format     Abstract available


  43. LEE KS, Santagostino SF, Li D, Ramjit A, et al
    Catheter-directed Intraportal Delivery of Endothelial Cell Therapy for Liver Regeneration: A Feasibility Study in a Large-Animal Model of Cirrhosis.
    Radiology. 2017 May 11:162617. doi: 10.1148/radiol.2017162617.
    PubMed     Text format     Abstract available

  44. KUHN JP, Meffert P, Heske C, Kromrey ML, et al
    Prevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging.
    Radiology. 2017 May 5. doi: 10.1148/radiol.2017161228.
    PubMed     Text format     Abstract available

    Transplant Proc

  45. SIBULESKY L, Hansen RN, Leca N, Blosser C, et al
    Landscape of Kidney Transplantation in Patients With Compensated Liver Disease: Results of a Survey of Transplant Surgeons in the United States.
    Transplant Proc. 2016;48:3268-3273.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.